Has Tarik Dabit received payments from drug or device companies?

Yes. Drug and device makers reported $3,059 in general payments to Tarik Dabit across 118 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tarik Dabit did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tarik Dabit come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tarik Dabit

Optometrist · San Rafael, CANPI 1447825021

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 118 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,267, more than ten times the $59 reported in 2021.

$3,059in general payments, 2019–2025

Across 118 payments — averaging $25.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$547
Alcon$471
Oyster Point Pharma, Inc.$316
Tarsus Pharmaceuticals, Inc.$271
Bausch & Lomb Americas Inc.$252
Sight Sciences, Inc.$225
plus $977 from 11 others

What the payments were for

Food & beverage$3,059100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	19	$547
Alcon	23	$471
Oyster Point Pharma, Inc.	9	$316
Tarsus Pharmaceuticals, Inc.	11	$271
Bausch & Lomb Americas Inc.	12	$252
Sight Sciences, Inc.	4	$225
Mallinckrodt Hospital Products Inc.	7	$196
ANI Pharmaceuticals, Inc.	8	$178
Sun Pharmaceutical Industries Inc.	7	$157
Thea Pharma Inc.	6	$129
Harrow Eye, LLC	2	$66
Biotissue Holdings Inc.	2	$65
Dompe US, Inc.	2	$62
Novartis	3	$58
Aerie Pharmaceuticals, Inc.	1	$24
Johnson & Johnson Surgical Vision, Inc.	1	$22
Kala Pharmaceuticals, Inc.	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TEARCARE SYSTEM$144

How this compares

$3,059 in reported general payments places this provider in the 85th percentile of 6,778 optometrist providers in California.

See all optometrist providers in California →

Other optometrist in San Rafael

Steve YoelinNewport Beach$4.1M
Matthew GellerSpring Valley$3.5M
Melissa EricksonDavis$522K
Omid KhodaiLake Forest$499K
Jason TuSan Diego$351K
Scott SchachterPismo Beach$312K
Alicia LauSan Diego$300K
Vin DangBakersfield$284K
Steven FerrucciSepulveda$272K
Katie ChuRosemead$271K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →